Sign in
Taking people in United StatesNo phase

Looking for early cancer changes in people with Barrett's esophagus using advanced endoscopy

Studies camera-based exams to spot early cancer changes in adults with Barrett's esophagus.

Key facts

Who runs it
Midwest Biomedical Research
Where
Kansas City, United StatesSee the site
Trial code
Registry title
Barrett's Esophagus Related Neoplasia (BERN) Project
Status
Recruiting
People taking part
150 people, planned
Started
15 May 2007
Expected to end
30 Dec 2026
Type of study
Observational
Record updated
22 November 2024

Who can take part

AI summary

From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.

The trial is looking for adults sent for an endoscopy (a camera test of the food pipe) to check or treat Barrett's esophagus. It studies new camera methods for finding early cancer changes.

Age
18-80 years
Sex
All sexes can join.
Disease stage
Barrett's esophagus, for screening or follow-up checks, or for endoscopic treatment of early cancer changes in the lining (early mucosal neoplasia).

Main reasons for not taking part

  • Current use of aspirin, NSAIDs or long-term blood thinners that cannot be stopped before the procedure
  • Very low platelet count or a blood clotting problem
  • Serious other illness that makes light sedation unsafe
  • Not able to give written consent

The registry criteria, word for word

Show all 7 criteriaShow less

Who can take part

  • 18-80 years
  • Patients must be able to provide written informed consent
  • Patients referred for endoscopy for screening/surveillance of BE or for endoscopic treatment of BE with early mucosal neoplasia

Who cannot take part

  • Current use of aspirin, non-steroidal anti-inflammatory agents(NSAIDs),or chronic anticoagulants that cannot be discontinued prior to the procedure
  • Any significant co-morbid condition that would prevent the safe administration of conscious sedation
  • Inability to provide written informed consent
  • Significant thrombocytopenia or coagulopathy

This trial is currently available in United States.

  • Kansas City VA Medical CenterKansas City, United StatesContact: April Higbee, RNTaking people

About the trial

What the trial wants to find out

* The use of high resolution endoscopy (HRE), narrow band imaging (NBI) and chromoendoscopy increases the detection rates of Barrett's esophagus (BE) and early neoplasia. * Endoscopic mucosal resection (EMR) will improve the accuracy for detection of dysplasia/early neoplasia.

Read full original descriptionShow less

Specific Aim 1 - To create a video-atlas of non-dysplastic and dysplastic/early neoplastic lesions in patients with BE. This will be used for training purposes and to assess learning curve associated with these new technologies.

Specific Aim 2 - To create a standardized classification system for the mucosal and vascular patterns observed in patients with BE.

Specific Aim 3 - To determine the interobserver agreement using the video-atlas for the mucosal and vascular patterns classification agreed upon.

Specific Aim 4 - To determine the endoscopic detection rate of esophageal cancer or precancerous lesions removed during endoscopy.

Specific Aim 5 - To determine the pathologic and clinical outcomes of patients undergoing EMR/ablation; including morbidity, mortality and complications of the procedure.

Results to date (June 2008) : this study is active and open to enrollment. Currently 26 patients have enrolled in this study at the Kansas City VA medical center. In order to participate, patients must be eligible for care at the KCVA hospital.

Questions to ask the study team

  1. How often do I need to come in, and for how long each time?
  2. Are travel costs paid?
  3. Can I keep my own doctor?
  4. What happens if I want to stop?

Contact the study team: see the registry record → Contacts and Locations

Print a page for my doctor

Data and sources

Registry record
Listed on ClinicalTrials.gov.How to verify a trial in the registry
Official title
Endoscopic Detection of Early Neoplasia in Patients With Barrett's Esophagus
Plain-language title
Looking for early cancer changes in people with Barrett's esophagus using advanced endoscopyGenerated from the registry record. The registry title is the official one.
AI summary
From the trial's eligibility criteria. Read by machine on 14 November 2026.
Record updated
22 November 2024